Enzo Biochem
ENZ
$1.09
Share price
-1.80%
Change (1 day)
-54.77%
Change (1 year)
Categories
Enzo Biochem (ENZ) - P/B ratio
P/B ratio as of May 2024 : 0.7889
According to Enzo Biochem's latest financial reports the company has a price-to-book ratio of 0.7889.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Enzo Biochem - P/B ratio (from 2001 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 0.9449 | -38.98% |
| 2022-12-31 | 1.55 | -33.56% |
| 2021-12-31 | 2.33 | 13.96% |
| 2020-12-31 | 2.05 | 28.07% |
| 2019-12-31 | 1.60 | -7.9% |
| 2018-12-31 | 1.73 | -59.57% |
| 2017-12-31 | 4.29 | 18.13% |
| 2016-12-31 | 3.63 | -17.32% |
| 2015-12-31 | 4.39 | -20.2% |
| 2014-12-31 | 5.50 | 50.81% |
| 2013-12-31 | 3.65 | 57.25% |
| 2012-12-31 | 2.32 | 123.09% |
| 2011-12-31 | 1.04 | -49.98% |
| 2010-12-31 | 2.08 | 18.19% |
| 2009-12-31 | 1.76 | 26.16% |
| 2008-12-31 | 1.39 | -59.19% |
| 2007-12-31 | 3.42 | -29.7% |
| 2006-12-31 | 4.86 | 28.19% |
| 2005-12-31 | 3.79 | -33.19% |
| 2004-12-31 | 5.67 | 13.45% |
| 2003-12-31 | 5.00 | 36.11% |
| 2002-12-31 | 3.67 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | 2.45 | 210.50% | 🇺🇸 USA |
 LabCorp LH | 2.23 | 182.15% | 🇺🇸 USA |
 RadNet RDNT | 5.22 | 561.45% | 🇺🇸 USA |
 Psychemedics PMD | 2.24 | 184.56% | 🇺🇸 USA |
 NeoGenomics
NEO | 2.05 | 159.46% | 🇺🇸 USA |
 Qiagen QGEN | 2.82 | 256.93% | 🇳🇱 Netherlands |